Army research and development-upec-targeting phage antimicrobials 2
Ended Definitive Contract Awarded Last action
- Contract number
- FA520923C0018
- Awardee
-
Intron Biotechnology, Inc. UEI W9NSFMJ645U8
- Awarding agency
-
Pacific Air Forces
Air Force, Department of Defense
- Obligated
- $138,601
Award facts
- Opportunity
-
- One-Step Open BAA, US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities Solicitation · FA520922S0001 · Posted Aug 31, 2022
- Contract value 100% obligated
- $138,600.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Research Development and Engineering Command Army Materiel Command, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
About this award
The Department of the Army Research Development and Engineering Command awarded a $138,600.63 definitive contract to Intron Biotechnology, Inc. for targeting phage antimicrobials research on September 15, 2023, with ultimate completion on September 14, 2024.
The award derives from a Broad Agency Announcement issued by the Department of the Air Force Pacific Air Forces and sponsored by the U.S. Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific. The solicitation, posted August 31, 2022 with submissions accepted until August 30, 2027, seeks fundamental research collaboration proposals across scientific domains including biological sciences, electromagnetic spectrum sciences, energy sciences, mechanical sciences, and quantum sciences, with anticipated awards ranging from $5,000 to $9.5 million over five years and approximately $1.9 million available annually. Work is performed in South Korea under a firm fixed-price arrangement. The BAA encourages innovative research that could enable new operational capabilities and technologies for military applications aligned with U.S. Army strategic interests in the Indo-Pacific region. Individual research projects range from seed projects valued between $20,000–$500,000 to international technology challenges with prize money between $10,000–$60,000, with periods of performance between six to sixty months depending on the specific project.
Quick answers
Who was awarded contract FA520923C0018?
FA520923C0018 was awarded to Intron Biotechnology, Inc. by Pacific Air Forces (Air Force) on September 15, 2023.
How much is contract FA520923C0018 worth?
The government has obligated $138,601 on FA520923C0018.
Which agency awarded contract FA520923C0018?
Pacific Air Forces (Air Force) awarded FA520923C0018, with funding from Research Development and Engineering Command (Army Materiel Command).
Was contract FA520923C0018 competed?
The extent of competition for FA520923C0018 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award